{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/25/3350295/0/en/sagimet-biosciences-advances-aurora-u-s-phase-3-trial-of-denifanstat-in-acne-toward-patient-enrollment-in-q4-2026.html", "message": "News view counter 900729 successfully enlarged"}